Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



A Phase 1, First-in-Human, Multicenter, Open-Label, Two Part Dose-Escalation and Cohort Expansion Study of Single-Agent ISB 1342 in Subjects with Previously Treated Multiple Myeloma

Multiple Myeloma

Multiple Myeloma
I
Mohan, Sanjay
NCT03309111
VICCHEMP17111

To learn more about any of our clinical
trials, call 615-936-8422.